Retinoic acid inhibits expression of E-selectin in endothelial cells and prolongs discordant xenograft survival.
Blakely
M L
ML
Sandoz Center for Immunobiology, Harvard Medical School, Boston, MA 02215.
Van der Werf
W J
WJ
Stuhlmeier
K
K
Dalmasso
A P
AP
Winkler
H
H
Bach
F H
FH
D000818:Animals; D015815:Cell Adhesion Molecules / Q000096:biosynthesis*; D019040:E-Selectin; D004730:Endothelium, Vascular / Q000378:metabolism*; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D009200:Myocardial Contraction; D051381:Rats; D011917:Rats, Inbred Lew; D011971:Receptors, Immunologic / Q000096:biosynthesis; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000502:physiology; D014212:Tretinoin / Q000494:pharmacology*
D015815:Cell Adhesion Molecules; D019040:E-Selectin; D011971:Receptors, Immunologic; D014212:Tretinoin